SARS-CoV-2 antibodies among people with cystic fibrosis prior to the vaccination campaign: A seroprevalence study in two specialized centres in Northern Italy

The prevalence of anti-SARS-CoV-2 antibodies in people with cystic fibrosis (CF) is largely unknown. We carried out a cross-sectional study between March and June 2021 with the aim of estimating the seroprevalence of anti-SARS-CoV-2 antibodies in two CF centres in Northern Italy. Total serum anti-SA...

Descripción completa

Detalles Bibliográficos
Autores principales: Alicandro, Gianfranco, Daccó, Valeria, Cariani, Lisa, Contarini, Martina, Morlacchi, Letizia Corinna, Rosazza, Chiara, Sciarrabba, Calogero Sathya, Ferraro, Federica, Orena, Beatrice Silvia, Gramegna, Andrea, Blasi, Francesco, Colombo, Carla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Cystic Fibrosis Society. Published by Elsevier B.V. 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666305/
https://www.ncbi.nlm.nih.gov/pubmed/34949558
http://dx.doi.org/10.1016/j.jcf.2021.12.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666305/
https://www.ncbi.nlm.nih.gov/pubmed/34949558
http://dx.doi.org/10.1016/j.jcf.2021.12.011

Ejemplares similares